76 related articles for article (PubMed ID: 35945682)
1. Association between
Ho TT; Perkins JB; Gonzalez R; Hicks JK; Martinez RA; Duranceau K; North B; Kim J; Teer JK; Yao J; Yoder SJ; Nishihori T; Bejanyan N; Pidala J; Elmariah H
Pharmacogenomics; 2024 Jan; 25(1):29-40. PubMed ID: 38189154
[No Abstract] [Full Text] [Related]
2. Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.
Naesens M; Lerut E; de Jonge H; Van Damme B; Vanrenterghem Y; Kuypers DR
J Am Soc Nephrol; 2009 Nov; 20(11):2468-80. PubMed ID: 19762492
[TBL] [Abstract][Full Text] [Related]
3. The hidden dangers of short-term glucocorticoid use in children: A genomic analysis.
Xu X; Li Y; Han T; Zhao Y; Wang X; Fu X; Mao H
Int Immunopharmacol; 2024 Jun; 135():112323. PubMed ID: 38788448
[TBL] [Abstract][Full Text] [Related]
4. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1.
Nady ME; El-Raouf OMA; El-Sayed EM
Mol Biol Rep; 2024 May; 51(1):608. PubMed ID: 38704766
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China.
Zeng L; Chen H; Xiang H; Zeng M; Zhou M; Tan C; Liu H; Chen G
Front Pharmacol; 2023; 14():1309930. PubMed ID: 38259264
[No Abstract] [Full Text] [Related]
6. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus induces a pro-fibrotic response in donor-derived human proximal tubule cells dependent on common variants of the CYP3A5 and ABCB1 genes.
Knops N; Ramazani Y; De Loor H; Goldschmeding R; Nguyen TQ; van den Heuvel LP; Levtchenko E; Kuypers DJ
Nephrol Dial Transplant; 2023 Feb; 38(3):599-609. PubMed ID: 35945682
[TBL] [Abstract][Full Text] [Related]
8. The functional implications of common genetic variation in CYP3A5 and ABCB1 in human proximal tubule cells.
Knops N; van den Heuvel LP; Masereeuw R; Bongaers I; de Loor H; Levtchenko E; Kuypers D
Mol Pharm; 2015 Mar; 12(3):758-68. PubMed ID: 25590378
[TBL] [Abstract][Full Text] [Related]
9. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
[TBL] [Abstract][Full Text] [Related]
10. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
Cho JH; Yoon YD; Park JY; Song EJ; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.
Sallustio BC; Noll BD; Hu R; Barratt DT; Tuke J; Coller JK; Russ GR; Somogyi AA
Br J Clin Pharmacol; 2021 Oct; 87(10):3901-3909. PubMed ID: 33646566
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients.
Kuypers DR; Naesens M; de Jonge H; Lerut E; Verbeke K; Vanrenterghem Y
Ther Drug Monit; 2010 Aug; 32(4):394-404. PubMed ID: 20526235
[TBL] [Abstract][Full Text] [Related]
13. Determination of tacrolimus, three mono-demethylated metabolites and a M1 tautomer in human whole blood by liquid chromatography - tandem mass spectrometry.
de Loor H; Vanhove T; Annaert P; Lescrinier E; Kuypers D
J Pharm Biomed Anal; 2021 Oct; 205():114296. PubMed ID: 34392130
[TBL] [Abstract][Full Text] [Related]
14. Progression of Interstitial Fibrosis and Tubular Atrophy in Low Immunological Risk Renal Transplants Monitored by Sequential Surveillance Biopsies: The Influence of TAC Exposure and Metabolism.
Chamoun B; Torres IB; Gabaldón A; Sellarés J; Perelló M; Castellá E; Guri X; Salcedo M; Toapanta NG; Cidraque I; Moreso F; Seron D
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33406589
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
